Literature DB >> 22207414

Mixed-effect circadian rhythm model for human erythrocyte acetylcholinesterase activity--application to the proof of concept of cholinesterase inhibition by acorn extract in healthy subjects with galantamine as positive control.

Seunghoon Han1, Jongtae Lee, Sangil Jeon, Taegon Hong, Dong-Seok Yim.   

Abstract

PURPOSE: The aim of this study was to develop a non-linear mixed effect circadian rhythm model of acetylcholinesterase (AChE) activity variation and to evaluate the inhibitory effect of acorn extract (2 g) and galantamine (16 mg), used as positive control, on human AChE in red blood cells (RBC).
METHODS: This was an open-label, randomized, three-way crossover study involving 12 healthy subjects who received one of the treatments in each study period: no treatment, acorn extract, and galantamine. RBC AChE activity was measured in peripheral blood samples collected at 0 (pre-dose), 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 12, 14, 16 and 24 h post-dose administration. Non-linear mixed effect modeling was performed using NONMEM (ver. 7.0).
RESULTS: The circadian variation of AChE activity was best described using two mixed effect cosine functions, with periods of 24 and 12 h, respectively. When the inhibitory effect terms were added, the model was significantly improved for both acorn extract and galantamine. In terms of the effect, a 2-g single dose of acorn extract showed AChE inhibition (about 5%) similar to that of a 16-mg single dose of galantamine, in the first 24 h after administration.
CONCLUSIONS: Based on the very pronounced inter- and intra-day variation in AChE activity in RBC, we conclude that the model-based approach is essential for the proof of concept and quantitation of AChE inhibition in human subjects.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22207414     DOI: 10.1007/s00228-011-1192-3

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  7 in total

1.  Inferential statistical method for analysis of nonsinusoidal hybrid time series with unequidistant observations.

Authors:  J R Fernández; R C Hermida
Journal:  Chronobiol Int       Date:  1998-03       Impact factor: 2.877

2.  National estimates of the prevalence of Alzheimer's disease in the United States.

Authors:  Ron Brookmeyer; Denis A Evans; Liesi Hebert; Kenneth M Langa; Steven G Heeringa; Brenda L Plassman; Walter A Kukull
Journal:  Alzheimers Dement       Date:  2011-01       Impact factor: 21.566

3.  Improved determination of acetylcholinesterase activity in human whole blood.

Authors:  F Worek; U Mast; D Kiderlen; C Diepold; P Eyer
Journal:  Clin Chim Acta       Date:  1999-10       Impact factor: 3.786

4.  Correlation between red blood cell acetylcholinesterase activity and neuromuscular transmission in organophosphate poisoning.

Authors:  Horst Thiermann; Ladislaus Szinicz; Peter Eyer; Thomas Zilker; Franz Worek
Journal:  Chem Biol Interact       Date:  2005-11-02       Impact factor: 5.192

5.  Acetylcholinesterase activity in cerebrospinal fluid of patients with Alzheimer's disease and senile dementia.

Authors:  S Nakano; T Kato; S Nakamura; M Kameyama
Journal:  J Neurol Sci       Date:  1986-09       Impact factor: 3.181

6.  Cerebrospinal fluid acetylcholinesterase activity in senile dementia of the Alzheimer type.

Authors:  L Tune; S Gucker; M Folstein; L Oshida; J T Coyle
Journal:  Ann Neurol       Date:  1985-01       Impact factor: 10.422

Review 7.  Acetylcholine esterase activity in mild cognitive impairment and Alzheimer's disease.

Authors:  Karl Herholz
Journal:  Eur J Nucl Med Mol Imaging       Date:  2008-03       Impact factor: 9.236

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.